1.
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, plac...
by Gadde, Kishore M, Dr
The Lancet (British edition), 2011, Vol.377 (9774), p.1341-1352
2.
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
by Greenway, Frank L, Prof
The Lancet (British edition), 2010, Vol.376 (9741), p.595-605
3.
Weight control behaviors of highly successful weight loss maintainers: the Portuguese Weight Control Registry
by Santos, Inês
Journal of behavioral medicine, 2016, Vol.40 (2), p.366-371
4.
Dietary Methionine Restriction Increases Fat Oxidation in Obese Adults with Metabolic Syndrome
by Plaisance, Eric P
The journal of clinical endocrinology and metabolism, 2011, Vol.96 (5), p.E836-E840
5.
The MC4R(I251L) Allele Is Associated with Better Metabolic Status and More Weight Loss after Gastric Bypass Surgery
by Mirshahi, Uyenlinh L
The journal of clinical endocrinology and metabolism, 2011, Vol.96 (12), p.E2088-E2096
6.
A gender-sensitised weight loss and healthy living programme for overweight and obese men delivered by Scottish Premier League football clubs (FFIT): a pragmatic randomised control...
by Hunt, Kate, Prof
The Lancet (British edition), 2014, Vol.383 (9924), p.1211-1221
7.
Role of Baseline Leptin and Ghrelin Levels on Body Weight and Fat Mass Changes after an Energy-Restricted Diet Intervention in Obese Women: Effects on Energy Metabolism
by Labayen, Idoia
The journal of clinical endocrinology and metabolism, 2011, Vol.96 (6), p.E996-E1000
8.
Baseline Sympathetic Nervous System Activity Predicts Dietary Weight Loss in Obese Metabolic Syndrome Subjects
by Straznicky, Nora E
The journal of clinical endocrinology and metabolism, 2012, Vol.97 (2), p.605-613
9.
GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
by Mullican, Shannon E
Nature medicine, 2017, Vol.23 (10), p.1150-1157
10.
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
by le Roux, Carel W, Prof
The Lancet (British edition), 2017, Vol.389 (10077), p.1399-1409
11.
Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention
by Liu, Ruixin
Nature medicine, 2017, Vol.23 (7), p.859-868
12.
Effectiveness and safety of interventions in reducing or preventing obesity and adverse outcomes in pregnancy
by Thangaratinam, S
Archives of disease in childhood. Fetal and neonatal edition, 2011, Vol.96 (Suppl 1), p.Fa110-Fa110
13.
14.
Food Addiction and Obesity: Evidence from Bench to Bedside
by Liu, Yijun
Journal of psychoactive drugs, 2010, Vol.42 (2), p.133-145
15.
Interventions to prevent and manage overweight or obesity in preschool children: A systematic review
by Ling, Jiying
International journal of nursing studies, 2016, Vol.53, p.270-289
16.
Developing a Culturally Responsive Lifestyle Intervention for Overweight/Obese U.S. Mexicans
by Leng, Jennifer
Journal of community health, 2021, Vol.47 (1), p.28-38
17.
Management of obesity
by Bray, George A, Prof
The Lancet (British edition), 2016, Vol.387 (10031), p.1947-1956
18.
MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency
by Clément, Karine
Nature medicine, 2018, Vol.24 (5), p.551-555
19.
Adipose lipid turnover and long-term changes in body weight
by Arner, P
Nature Medicine, 2019, Vol.25 (9), p.1385-1389
20.
Management of obesity: improvement of health-care training and systems for prevention and care
by Dietz, William H, Dr
The Lancet (British edition), 2015, Vol.385 (9986), p.2521-2533
